An Athlete’s Battle On and Off the Field: Grace Taylor's story
A Division I lacrosse player at Harvard navigates a life-changing cancer diagnosis with support from the Cancer Center's AYA program.
Past themes of Annual Workshops (begun in the second year of the CSIBD) include:
A Division I lacrosse player at Harvard navigates a life-changing cancer diagnosis with support from the Cancer Center's AYA program.
U.S. News & World Report released its “Best Hospitals” for 2024-2025 and Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health care system, has again earned a spot on the annual Honor Roll. MGH also ranked #1 in the nation in psychiatry.
Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy could lead to better outcomes.
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.
Read how proton therapy saved the life of 19-year-old Chris Kobos after he was diagnosed with a rare chordoma.
MGH neighbor and West End staple, The West End Museum, is once again open to the public this summer after being closed for more than two years because of a burst pipe. The newly renovated and reimagined space formally reopened in May.
A Division I lacrosse player at Harvard navigates a life-changing cancer diagnosis with support from the Cancer Center's AYA program.
U.S. News & World Report released its “Best Hospitals” for 2024-2025 and Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health care system, has again earned a spot on the annual Honor Roll. MGH also ranked #1 in the nation in psychiatry.
Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy could lead to better outcomes.
Myocarditis is driven by a different immune response than the anti-tumor one, suggesting that the serious complication could one day be managed without halting cancer therapy.